130 related articles for article (PubMed ID: 4644242)
1. Anaphylatoxin formation by contact activation of plasma. 3. Fixation of two different anaphylatoxin-forming complexes on zymosan.
Brade V; Schmidt G; Vogt W
Eur J Immunol; 1972 Apr; 2(2):180-6. PubMed ID: 4644242
[No Abstract] [Full Text] [Related]
2. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
[No Abstract] [Full Text] [Related]
3. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
[No Abstract] [Full Text] [Related]
4. Anaphylatoxin formation by contact activation of plasma. I. Activation by zymosan without participation of antibody.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):290-5. PubMed ID: 4945685
[No Abstract] [Full Text] [Related]
5. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
[No Abstract] [Full Text] [Related]
6. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
Stitzel AE; Spitzer RE
J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
[No Abstract] [Full Text] [Related]
7. Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.
Goldlust MB; Shin HS; Hammer CH; Mayer MM
J Immunol; 1974 Sep; 113(3):998-1007. PubMed ID: 4213402
[No Abstract] [Full Text] [Related]
8. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
[No Abstract] [Full Text] [Related]
9. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
Lint TF; Behrends CL; Baker PJ; Gewurz H
J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
[TBL] [Abstract][Full Text] [Related]
10. Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
Koethe SM; Austen KF; Gigli I
J Immunol; 1973 Feb; 110(2):390-400. PubMed ID: 4684033
[No Abstract] [Full Text] [Related]
11. Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.
Gaither TA; Frank MM
J Immunol; 1973 Feb; 110(2):482-9. PubMed ID: 4684035
[No Abstract] [Full Text] [Related]
12. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
Gigli I; Koethe S; Austen KF
Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
[No Abstract] [Full Text] [Related]
13. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
May JE; Frank MM
J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
[No Abstract] [Full Text] [Related]
14. Anaphylatoxin in its relation to the complement system.
Jensen J
Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
[TBL] [Abstract][Full Text] [Related]
15. Role of complement in immune lysis of Trypanosoma cruzi.
Anziano DF; Dalmasso AP; Lelchuk R; Vásquez C
Infect Immun; 1972 Nov; 6(5):860-4. PubMed ID: 4564786
[TBL] [Abstract][Full Text] [Related]
16. [PROPERDIN AND ANAPHYLATOXIN].
WILLEMS G
Rev Immunol Ther Antimicrob; 1963; 27():285-90. PubMed ID: 14111198
[No Abstract] [Full Text] [Related]
17. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.
Takahashi M; Takahashi S; Hirose S
Prog Allergy; 1980; 27():134-66. PubMed ID: 6986046
[No Abstract] [Full Text] [Related]
18. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
Brade V; Nicholson A; Bitter-Suermann D; Hadding U
J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
[No Abstract] [Full Text] [Related]
19. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
Linscott WD
J Immunol; 1972 Dec; 109(6):1327-36. PubMed ID: 4673616
[No Abstract] [Full Text] [Related]
20. Binding of the complement intermediate C56 to zymosan in acute phase human sera.
Baker PJ; Rubin LG; Lint TF; McLeod BC; Gewurz H
Clin Exp Immunol; 1975 Apr; 20(1):113-24. PubMed ID: 1106918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
